Our goal was fill this gap and to characterize the effect of therapy involving ACE-I or/and ExT on a broad spectrum of angiotensin (Ang) peptides in relation to cardiac function in the course of HF to find out whether Ang-(1–7)/Ang II ratio could serve as a reliable and mechanistically-relevant biomarker. This evidence concerns the gene AGT and hydrops fetalis.